Abstract:γ-Aminobutyric acid (GABA) is the most prevalent inhibitory neurotransmitter in the mammalian brain and has been found to play an important role in the pathogenesis or the expression of many neurological diseases, including epilepsy. Although GABA can act on different receptor subtypes, the component of the GABA system that is most critical to modulation of seizure activity is the GABA A -receptor-chloride (Cl − ) channel complex, which controls the movement of Cl − ions across the neuronal membrane. In the mature brain, binding of GABA to GABA A receptors evokes a hyperpolarising (anticonvulsant) response, which is mediated by influx of Cl − into the cell driven by its concentration gradient between extracellular and intracellular fluid. However, in the immature brain and under certain pathological conditions, GABA can exert a paradoxical depolarising (proconvulsant) effect as a result of an efflux of chloride from high intracellular to lower extracellular Cl − levels. Extensive preclinical and clinical evidence indicates that alterations in GABAergic inhibition caused by drugs, toxins, gene defects or other disease states (including seizures themselves) play a causative or contributing role in facilitating or maintaning seizure activity. Conversely, enhancement of GABAergic transmission through pharmacological modulation of the GABA system is a major mechanism by which different antiseizure medications exert their therapeutic effect. In this article, we review the pharmacology and function of the GABA system and its perturbation in seizure disorders, and highlight how improved understanding of this system offers opportunities to develop more efficacious and better tolerated antiseizure medications. We also review the available data for the two most recently approved antiseizure medications that act, at least in part, through GABAergic mechanisms, namely cenobamate and ganaxolone. Differences in the mode of drug discovery, pharmacological profile, pharmacokinetic properties, drug–drug interaction potential, and clinical efficacy and tolerability of these agents are discussed.

The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain

Gaba(A) Receptor Mutations Associated with Generalized Epilepsies

GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop

Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy

Transcriptional Control of Gad2.

Regulation of Inhibitory Signaling at the Receptor and Cellular Level; Advances in Our Understanding of GABAergic Neurotransmission and the Mechanisms by Which It Is Disrupted in Epilepsy

Evolution of Neurotransmitter Gamma-Aminobutyric Acid, Glutamate and Their Receptors

Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease

GABA tone regulation and its cognitive functions in the brain

Glutamate and GABA A receptor crosstalk mediates homeostatic regulation of neuronal excitation in the mammalian brain

Serial Deletion Reveals Structural Basis and Stability for the Core Enzyme Activity of Human Glutaminase 1 Isoforms: Relevance to Excitotoxic Neurodegeneration.

Glutaminase in Microglia: A Novel Regulator of Neuroinflammation

A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders

Effects of psoralidin on the expression of glutamate decarboxylases and inhibitory synapse development

GABA(A) receptor diversity and pharmacology

Epigenetic regulation of neurotransmitter signaling in neurological disorders

New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System

Glutamate Decarboxylase from Lactic Acid Bacteria—A Key Enzyme in GABA Synthesis

The Progress of GABAB Receptor Regulation Mechanism

Transcriptional Regulation of GAD1 GABA Synthesis Gene in the Prefrontal Cortex of Subjects with Schizophrenia

Glycine and glycine receptor signaling in hippocampal neurons: diversity, function and regulation.